(Q86247281)

English

Itolizumab provides sustained remission in plaque psoriasis: a 5-year follow-up experience

scientific article published on 12 December 2014

Statements

Itolizumab provides sustained remission in plaque psoriasis: a 5-year follow-up experience (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit